323 related articles for article (PubMed ID: 33522485)
1. The genetic landscape for amyloid beta fibril nucleation accurately discriminates familial Alzheimer's disease mutations.
Seuma M; Faure AJ; Badia M; Lehner B; Bolognesi B
Elife; 2021 Feb; 10():. PubMed ID: 33522485
[TBL] [Abstract][Full Text] [Related]
2. Application of optogenetic Amyloid-β distinguishes between metabolic and physical damages in neurodegeneration.
Lim CH; Kaur P; Teo E; Lam VYM; Zhu F; Kibat C; Gruber J; Mathuru AS; Tolwinski NS
Elife; 2020 Mar; 9():. PubMed ID: 32228858
[TBL] [Abstract][Full Text] [Related]
3. An atlas of amyloid aggregation: the impact of substitutions, insertions, deletions and truncations on amyloid beta fibril nucleation.
Seuma M; Lehner B; Bolognesi B
Nat Commun; 2022 Nov; 13(1):7084. PubMed ID: 36400770
[TBL] [Abstract][Full Text] [Related]
4. Familial Alzheimer's Disease Mutations within the Amyloid Precursor Protein Alter the Aggregation and Conformation of the Amyloid-β Peptide.
Hatami A; Monjazeb S; Milton S; Glabe CG
J Biol Chem; 2017 Feb; 292(8):3172-3185. PubMed ID: 28049728
[TBL] [Abstract][Full Text] [Related]
5. Fibrillar Aβ triggers microglial proteome alterations and dysfunction in Alzheimer mouse models.
Sebastian Monasor L; Müller SA; Colombo AV; Tanrioever G; König J; Roth S; Liesz A; Berghofer A; Piechotta A; Prestel M; Saito T; Saido TC; Herms J; Willem M; Haass C; Lichtenthaler SF; Tahirovic S
Elife; 2020 Jun; 9():. PubMed ID: 32510331
[TBL] [Abstract][Full Text] [Related]
6. Dynamics of protofibril elongation and association involved in Aβ42 peptide aggregation in Alzheimer's disease.
Ghosh P; Kumar A; Datta B; Rangachari V
BMC Bioinformatics; 2010 Oct; 11 Suppl 6(Suppl 6):S24. PubMed ID: 20946608
[TBL] [Abstract][Full Text] [Related]
7. Characterization of the unique In Vitro effects of unsaturated fatty acids on the formation of amyloid β fibrils.
Eto M; Hashimoto T; Shimizu T; Iwatsubo T
PLoS One; 2019; 14(7):e0219465. PubMed ID: 31291354
[TBL] [Abstract][Full Text] [Related]
8. Familial Alzheimer's disease mutations at position 22 of the amyloid β-peptide sequence differentially affect synaptic loss, tau phosphorylation and neuronal cell death in an ex vivo system.
Tackenberg C; Kulic L; Nitsch RM
PLoS One; 2020; 15(9):e0239584. PubMed ID: 32966331
[TBL] [Abstract][Full Text] [Related]
9. Insights into the Molecular Mechanisms of Alzheimer's and Parkinson's Diseases with Molecular Simulations: Understanding the Roles of Artificial and Pathological Missense Mutations in Intrinsically Disordered Proteins Related to Pathology.
Coskuner-Weber O; Uversky VN
Int J Mol Sci; 2018 Jan; 19(2):. PubMed ID: 29364151
[TBL] [Abstract][Full Text] [Related]
10. How do membranes initiate Alzheimer's Disease? Formation of toxic amyloid fibrils by the amyloid β-protein on ganglioside clusters.
Matsuzaki K
Acc Chem Res; 2014 Aug; 47(8):2397-404. PubMed ID: 25029558
[TBL] [Abstract][Full Text] [Related]
11. On the role of sidechain size and charge in the aggregation of A
Yang X; Meisl G; Frohm B; Thulin E; Knowles TPJ; Linse S
Proc Natl Acad Sci U S A; 2018 Jun; 115(26):E5849-E5858. PubMed ID: 29895690
[TBL] [Abstract][Full Text] [Related]
12. Neurons derived from sporadic Alzheimer's disease iPSCs reveal elevated TAU hyperphosphorylation, increased amyloid levels, and GSK3B activation.
Ochalek A; Mihalik B; Avci HX; Chandrasekaran A; Téglási A; Bock I; Giudice ML; Táncos Z; Molnár K; László L; Nielsen JE; Holst B; Freude K; Hyttel P; Kobolák J; Dinnyés A
Alzheimers Res Ther; 2017 Dec; 9(1):90. PubMed ID: 29191219
[TBL] [Abstract][Full Text] [Related]
13. A three-dimensional human neural cell culture model of Alzheimer's disease.
Choi SH; Kim YH; Hebisch M; Sliwinski C; Lee S; D'Avanzo C; Chen H; Hooli B; Asselin C; Muffat J; Klee JB; Zhang C; Wainger BJ; Peitz M; Kovacs DM; Woolf CJ; Wagner SL; Tanzi RE; Kim DY
Nature; 2014 Nov; 515(7526):274-8. PubMed ID: 25307057
[TBL] [Abstract][Full Text] [Related]
14. Unique molecular signatures of Alzheimer's disease amyloid β peptide mutations and deletion during aggregate/oligomer/fibril formation.
Poduslo JF; Howell KG
J Neurosci Res; 2015 Mar; 93(3):410-23. PubMed ID: 25377128
[TBL] [Abstract][Full Text] [Related]
15. Structure and intermolecular dynamics of aggregates populated during amyloid fibril formation studied by hydrogen/deuterium exchange.
Carulla N; Zhou M; Giralt E; Robinson CV; Dobson CM
Acc Chem Res; 2010 Aug; 43(8):1072-9. PubMed ID: 20557067
[TBL] [Abstract][Full Text] [Related]
16. Amyloid-β40 E22K fibril in familial Alzheimer's disease is more thermostable and susceptible to seeding.
Lee MC; Liao YH; Chen SH; Chen YR
IUBMB Life; 2022 Aug; 74(8):739-747. PubMed ID: 34724333
[TBL] [Abstract][Full Text] [Related]
17. Pathologic polyglutamine aggregation begins with a self-poisoning polymer crystal.
Kandola T; Venkatesan S; Zhang J; Lerbakken BT; Von Schulze A; Blanck JF; Wu J; Unruh JR; Berry P; Lange JJ; Box AC; Cook M; Sagui C; Halfmann R
Elife; 2023 Nov; 12():. PubMed ID: 37921648
[TBL] [Abstract][Full Text] [Related]
18. Modeling the β-secretase cleavage site and humanizing amyloid-beta precursor protein in rat and mouse to study Alzheimer's disease.
Serneels L; T'Syen D; Perez-Benito L; Theys T; Holt MG; De Strooper B
Mol Neurodegener; 2020 Oct; 15(1):60. PubMed ID: 33076948
[TBL] [Abstract][Full Text] [Related]
19. Understanding amyloid fibril nucleation and aβ oligomer/drug interactions from computer simulations.
Nguyen P; Derreumaux P
Acc Chem Res; 2014 Feb; 47(2):603-11. PubMed ID: 24368046
[TBL] [Abstract][Full Text] [Related]
20. Structural variation in amyloid-β fibrils from Alzheimer's disease clinical subtypes.
Qiang W; Yau WM; Lu JX; Collinge J; Tycko R
Nature; 2017 Jan; 541(7636):217-221. PubMed ID: 28052060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
